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Summary
Cell migration entails protrusion of lamellipodia, densely
packed networks of actin filaments at the cell front. Fila-
ments are generated by nucleation, likely mediated by
Arp2/3 complex and its activator Scar/WAVE [1]. It is unclear
whether formins contribute to lamellipodial actin filament
nucleation or serve as elongators of filaments nucleated by
Arp2/3 complex [2]. Here we show that the Diaphanous-
related formin FMNL2, also known as FRL3 or FHOD2 [3],
accumulates at lamellipodia and filopodia tips. FMNL2 is
cotranslationally modified by myristoylation and regulated
by interaction with the Rho-guanosine triphosphatase
Cdc42. Abolition of myristoylation or Cdc42 binding inter-
feres with proper FMNL2 activation, constituting an essen-
tial prerequisite for subcellular targeting. In vitro, C-terminal
FMNL2 drives elongation rather than nucleation of actin
filaments in the presence of profilin. In addition, filament
ends generated by Arp2/3-mediated branching are captured
and efficiently elongated by the formin. Consistent with
these biochemical properties, RNAi-mediated silencing of
FMNL2 expression decreases the rate of lamellipodia protru-
sion and, accordingly, the efficiency of cell migration. Our
data establish that the FMNL subfamily member FMNL2 is
a novel elongation factor of actin filaments that constitutes
the first Cdc42 effector promoting cell migration and actin
polymerization at the tips of lamellipodia.Results and Discussion
Diaphanous-related formins are regulated by autoinhibition,
typically released by interaction with guanosine triphosphate8Present address: Rosenstiel Basic Medical Science Research Center,
Brandeis University, 415 South Street, Waltham, MA 02454, USA
*Correspondence: krottner@uni-bonn.de(GTP)-bound, active versions of specific Rho family guanosine
triphosphatases (GTPases) [3, 4]. They can generate bundles
composed of linear actin filaments, like those found in
microvilli or filopodia [5]. Among 15 human formins, Drf3
(murine version, mDia2) is established best to induce filopodia
[6–8], but its role in lamellipodia formation is ambiguous
because its RNAi-mediated knockdown both inhibited [8]
and promoted [9] lamellipodia. Although expression of active
Drf3 variants drives explosive filopodia formation [6, 8],
redundancy with related formins is likely [10], because we
observed no RNAi phenotype in HeLa cells (J.B. and K.R.,
unpublished data).
To find additional formins operating in lamellipodia and filo-
podia protrusion, we first explored formin messenger RNA
(mRNA) expression in a panel of human and murine cell lines
using microarrays. Whereas mDia2/Drf3 messages were
mostly absent in motile murine fibroblasts or B16-F1 cells
[6], we found significant Diaphanous-related formin FMNL2/
FRL3 mRNA (Figure 1A) and protein (Figure 1B) in all cell
lines. Interestingly, high FMNL2 expression correlated with
increased invasiveness of colorectal cancer cells [11, 12], sug-
gesting a role in cell migration. In murine cells, the antibody
originally raised against FMNL2 also cross-reacted with
a smaller protein (Figure 1B), confirmed byRNAi to correspond
to the closely related FMNL3/FRL2 (see Figure S3G available
online) [3, 13]. Accordingly, we only detected FMNL3/FRL2
mRNA in murine cell lines (Figure 1A), whereas the mostly
hematopoietic FMNL1/FRL1 appeared below threshold in all
lines, in agreement with western blotting (F.K. and K.R.,
unpublished data). FMNL2 harbors the canonical domains of
a Diaphanous-related formin—the autoregulatory DID and
DAD domains, and the FH1-FH2 module proposed to mediate
actin assembly [4] (Figure 1C). FMNL2 has two splice isoforms
with slight C-terminal sequence variation [14]: the A (short) and
B (long) variants (Figure 1C). As before [15], all experiments
shown here were done with the B variant. Immunolabelings
revealed prominent staining of endogenous FMNL2/FMNL3
in lamellipodia (Figure 1D; Figure S1A), suggesting involve-
ment in actin-based protrusion. Lamellipodial accumulation
of FMNL2 was confirmed by video microscopy of the same
cell type expressing an enhanced green fluorescent protein
(EGFP)-tagged variant, rendered active through DAD domain
truncation (Figure 1E; Movie S1). Like active Drf3-DDAD [6]
or different, active FMNL3 variants [13], activated FMNL2
also accumulated at filopodial tips (Figure 1E), but unlike
Drf3-DDAD [6], it did not suppress lamellipodia, indicating
that FMNL2 (and perhaps FMNL3) might be involved in both
filopodia and lamellipodia formation (Figure 1E). Accumulation
in the lamellipodium was abolished during retraction (Fig-
ure 1E, asterisk), as expected for a potential protrusion
regulator, but unusually, FMNL2 could also associate with
retracting or tail edges (Movie S1). Moreover, FMNL2 dislocal-
ized much more slowly than vasodilator-stimulated phospho-
protein (VASP) during lamellipodial retraction (Figures S1B and
S1C), suggesting tight association with and regulation of
lamellipodial actin filaments. We confirmed specific enrich-
ment of FMNL2DDAD in lamellipodia with an inert volume
marker (Figure S1D), Arp2/3 complex staining (Figure S1E),
Figure 1. FMNL2 Is Widely Expressed and Accumulates at the Tips of Lamellipodia and Filopodia
(A) Microarray analyses indicating high levels of FMNL2 gene transcription in various murine and human cell lines.
(B) Confirmation of FMNL2 expression bywestern blotting in cell lines as in (A). a-tubulin was used as loading control; FMNL2migrates at an apparentmolec-
ular weight of 150 kDa plusw30 kDa for the EGFP-tagged variant. The additional band most prominent in murine cell lines corresponded to FMNL3 (Fig-
ure S3G), as indicated.
(C) Domain structure and splice variants of FMNL2 are illustrated. DID, Diaphanous inhibitory domain; DD, dimerization domain; FH1/2, formin homology 1/2;
WH2, WASP homology 2; DAD, Diaphanous autoregulatory domain. FMNL2 is spliced into at least two isoforms, designated FMNL2A (Uniprot identifier
Q96PY5-1) and FMNL2B (Uniprot identifier Q96PY5-3), which differ at their C-terminal ends as depicted.
(D) Immunolabeling showing that endogenous FMNL2/FMNL3 are concentrated in F-actin-rich lamellipodia (white arrows, zoom-in: Figure S1A) of B16-F1
melanoma cells. Scale bar represents 30 mm.
(E) EGFP-tagged, constitutively active FMNL2 (DDAD) targets to the tips of protruding filopodia (white arrows) and lamellipodia (white arrowheads) but is
displaced in the course of retraction (asterisk; see also Figures S1B and S1C). Time is in s; scale bars represent 2 mm (left panel) and 10 mm (right panel).
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Abi-1 (Figure S1F). Despite its proposed function as bundling
protein [15], we observed no colocalization with fascin and
bundled actin in microspikes (Figure S1F).
Next, we determined potential interactions of FMNL2 with
specific Rho-GTPases. Pull-down experiments using GST- or
MBP-tagged GTPases and EGFP-tagged FMNL2 variants
harboring the GTPase binding domain (GBD) (Figure 1C)
showed nucleotide-dependent interactions with Cdc42 and
Rac1, but not RhoA, RhoD, Rif, or RhoG (Figure S2A; positive
controls in Figure S2B). GST-Cdc42 or -Rac1 variants could
also directly pull down purified FMNL2 residues 1–489
(FMNL2NCC), proving direct interactions and indicating
Cdc42 being much more effective (Figure S2D). Using
isothermal titration calorimetry (ITC), the purified N terminus
of FMNL2 (FMNL2N) exclusively interacted with Cdc42 associ-
ated with the nonhydrolyzable GTP analog GppNHp (Figure
2A), but not with GDP-loaded Cdc42 (Figure 2B) nor with activeRac1 (Figure 2C). We conclude that FMNL2 is a specific down-
stream effector of Cdc42 but likely not of related small
GTPases such as Rac1 or RhoA.
In cells, ectopically expressed EGFP-tagged FMNL2 was
entirely cytosolic (Figure 2D), presumably due to autoinhibition
[6], but potently targeted to the cell periphery upon coexpres-
sion of constitutively active Cdc42 (Figure 2D). Consistent with
the ITC data, coexpression of constitutively active Rac1 did
not cause peripheral targeting, although the latter induced
prominent lamellipodia (Figure 2D), nor did coexpression of
EGFP-FMNL2 with constitutively active RhoA (Figure S2G) or
RhoC (Figure S2H), despite strong stress fiber induction.
Again, FMNL2N failed to interact with active RhoA in ITC
assays (Figure S2E). Together, these data establish FMNL2
as the first Cdc42 effector capable of targeting to the tips of
lamellipodia.
Besides interaction with Rho-GTPases, formins might be
regulated by protein modifications. For instance, FMNL1 was
Figure 2. FMNL2 Is Regulated by Cdc42 and Myristoylation
(A–C) ITCmeasurements of the interactions between triphosphate-loaded Rho-GTPases and purified FMNL2 N terminus (FMNL2N, aa 2–379). (A) Binding of
Cdc42,GppNHp to FMNL2N revealed a dissociation constant (KD) of 3.136 0.38 mM.DH and TDS corresponded to25.336 0.16 kcal/mol and 2.19 kcal/mol,
respectively, with a molar ratio of 0.51. No binding was detected with either diphosphate-loaded Cdc42 (B) or Rac1,GppNHp (C).
(D) Subcellular targeting of FMNL2 is affected by constitutively active Cdc42, but not Rac1. EGFP-FMNL2 expressed in B16-F1 cells is entirely cytosolic (top)
but targeted to the cell periphery upon coexpression of active Cdc42 (middle). Constitutively active Rac1 (bottom) lacked this effect, consistent with ITC
measurements (C) and despite significant lamellipodia stimulation. Scale bar represents 10 mm.
(E) FMNL2 and FMNL3 (but not FMNL1) harbor the canonical myristoylation consensus sequence MGXXXS at their N termini.
(F) FMNL2B capable of myristoylation due to C-terminal tagging with EGFP (myr-FMNL2-EGFP) targets to protruding lamellipodia in B16-F1 cells (left), but
an analogous construct harboring a point mutation prohibiting myristoylation (G2A-FMNL2-EGFP) does not (middle). Targeting of G2A-FMNL2-EGFP is
restored by coexpression with constitutively active Cdc42 (right). Scale bars represent 10 mm.
(G) Myristoylation and Cdc42 both mediate activation of FMNL2, but not its subcellular targeting. Summary of subcellular localization of constructs as
depicted in B16-F1 cells or fibroblasts lacking Cdc42 (Cdc422/2) and their parental controls (Cdc42+/2). For images see Figures S3A and S3B. Specific accu-
mulation in the lamellipodium was categorized as follows: +++, very strong localization; ++, clear, specific enrichment; +, weak enrichment; (+), weak local-
ization in some but not all cells examined; (2), no enrichment; n.d., not determined. Note that nonmyristoylatable, active FMNL2 (G2A-FMNL2DDAD-EGFP)
localizes to lamellipodia even in Cdc422/2 cells.
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Figure 3. FMNL2 Requires Profilin to Elongate Actin Filaments Derived from Spontaneous or Arp2/3 Complex-Mediated Nucleation
(A) FMNL2 inhibits actin polymerization in the absence of profilin. A total of 3 mM G-actin (10% pyrene labeled) was polymerized in 13 KMEI buffer in the
presence of FMNL2(8P)-C at concentrations as indicated.
(B) FMNL2 processively assembles actin filaments. Spontaneous assembly of 1.3 mM actin (23% Alexa 488 labeled) in the presence of 20 nM FMNL2(8P)-C
(top) or 5 nM FMNL2(8P)-C and 5 mM profilin (middle) or 10 nM FMNL2(21P)-C and 5 mM profilin (bottom) monitored by TIRFM. Circles mark barbed ends
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1009previously suggested to be myristoylated [16], and indeed,
both FMNL2 and FMNL3 harbor the canonical consensus
sequence for N-terminal myristoylation [17] (Figure 2E).
Consistently, mass spectrometry proved that ectopically ex-
pressed FMNL2N can be myristoylated in E. coli (Figures
S2I–S2K). N-terminal protein tagging blocks N-terminal myris-
toylation [17], so to test whether myristoylation contributes to
subcellular targeting and/or activation of FMNL2, we fused
EGFP C-terminally to the full-length formin. Strikingly,
unlike the N-terminally tagged protein (Figure 2D), this
variant (myr-FMNL2-EGFP) localized to lamellipodia tips in
B16-F1 cells even in the absence of Rho-GTPase coexpres-
sion (Figure 2F; Movie S2), similar to the active, EGFP-DDAD
variant (Figure 1E). Importantly, this effect was largely abol-
ished by a G/A mutation at position 2 (Figure 2F), proving
its dependence on myristoylation, but was reverted by
ectopic coexpression of constitutively active Cdc42 (Figures
2F and 2G). Systematic analysis of subcellular targeting of
FMNL2 variants in B16-F1 cells compared to fibroblasts
heterozygous or homozygous null for the Cdc42 gene [18]
established that both myristoylation and active Cdc42
contribute to FMNL2 activation. Subcellular targeting,
however, also occurred in the absence of both signals, given
that the formin lacked the DAD domain required for autoinhi-
bition (Figure 2G; for representative images see Figures S3A
and S3B). Unlike previous suggestions [16, 19], our data
demonstrate that FMNL lipidation and Rho-GTPase interac-
tion are dispensable for accumulation in lamellipodia and filo-
podia but, instead, control release from autoinhibition at or
close to the plasma membrane. Finally, myristoylation does
also not significantly affect FMNL2 interaction with Cdc42, as-
sayed by either pull-down or ITC (Figures S2C and S2F). The
recruitment factor to the tips of lamellipodia and filopodia
remains unknown.
To explore how FMNL2 influences actin dynamics, we
expressed and purified fragments from the C-terminal half of
FMNL2, comprising the FH1 and FH2 domains essential for
actin assembly in most formins [4], as well as the WH2 and
DAD domains (Figure 1C). FH1 and FH2 domains work
together in actin assembly by interactions with the actin-
monomer binding proteins profilin and actin, respectively [4],
but for FMNL3, the WH2 domain has also been implicated in
actin binding [20]. In FMNL2, the wild-type FH1 sequence
harbors long stretches of consecutive proline residues
thought to recruit profilin-actin complexes [4]. To aid bacterial
expression, we engineered synthetic variants of C-terminal
FMNL2 with modified numbers of consecutive FH1 domain
prolines, FMNL2(8P)-C and FMNL2(21P)-C (for purity see
Figure S3C). FMNL2(8P)-C inhibited actin polymerizationcaptured by FMNL2 molecules passively absorbed to the coverslip; arrows indi
bars represent 10 mm. See Movie S3.
(C) Examples of individual, spontaneously growing, or FMNL2(21P)-C-assemb
profilin.
(D) Quantification of actin filament elongation rates as determined by TIRFM.
(E) FMNL2 does not significantly enhance nucleation in the absence or presen
profilin (5 mM) or FMNL2(21P)-C (10 nM), or both, as indicated.
(F) FMNL2 elongates actin filaments nucleated by Arp2/3 complex. Spontaneo
proteins indicated. Arrowheads mark branch points generated by Arp2/3 com
FMNL2 in the absence of profilin. White circles mark barbed ends of sponta
mark dim filaments elongated by FMNL2. Scale bars represent 5 mm. See Mov
(G) Quantification of filaments elongated by FMNL2(21P)-C and profilin in the p
(H) Quantification of actin filament elongation from experiments as shown in (G
Error bars in (D), (E), (G), and (H) represent mean 6 SD from at least three inde
See Figure S3.in pyrene-actin assays in a concentration-dependent manner
(Figure 3A; Figure S3D), likely mediated by formin interaction
with the fast-growing barbed ends of actin filaments
(Kapp of w18 nM; see Figure S3D), leading to interference
with their elongation. Consistently, FMNL2(8P)-C also pro-
tected filaments from depolymerization, although not as
efficiently as heterodimeric capping protein (Figure S3E).
FMNL(21)-C also inhibited pyrene-actin assembly (data not
shown).
To test formin action at the barbed end more directly, we
performed total internal reflection fluorescence microscopy
(TIRFM) to visualize and quantify individual actin filament
barbed ends growing in the presence or absence of the
formin and profilin. Without either factor, barbed ends grew
at a rate of w10 subunits/s (Figure 3D; data not shown). In
contrast, addition of FMNL2(8P)-C (data not shown) or
FMNL2(21P)-C alone abrogated barbed-end growth (Figures
3B–3D; Movie S3). However, profilin addition induced
assembly of dim, fast-growing filaments, as reported for
other formins that prefer to incorporate nonlabeled actin
under these conditions [21] (Figures 3B–3D). Also, frequent
filament buckling was observed (Figure 3B; Movie S3), likely
caused by formin molecules passively attaching to the cover-
slip surface, and indicative of processive barbed-end elonga-
tion. As opposed to other formins like mDia2 (Figure S3F),
both FMNL2 fragments did not significantly change the
number of filaments observed (data not shown; Figure 3E),
regardless of the presence of profilin. Addition of the
latter to actin alone strongly reduced filament numbers, as
expected, but similar values were obtained upon further
addition of FMNL2(21P)-C (Figure 3E). These results differ
somewhat from a report that the FMNL3 C terminus could
accelerate actin assembly even in the absence of profilin
[20], but whether this was due to nucleation or severing re-
mained uncertain [13]. Our data suggest that FMNL2 is at
best a very weak nucleator but can processively elongate
actin filaments in the presence of profilin. Within the lamelli-
podium, filaments, presumably nucleated by Arp2/3 complex
[22, 23], could be captured and elongated by FMNL2. To test
whether FMNL2 could elongate filaments generated by Arp2/
3-mediated branching, we assayed FMNL2 with or without
profilin in the presence of Arp2/3 complex and its activator
Scar1-VCA (see also Movie S4). Activated Arp2/3 complex
generated growing filament networks harboring multiple
branches, which was reduced by FMNL2(21)-C alone (Fig-
ure 3F), presumably because barbed ends were efficiently
capped. However, profilin addition enabled accelerated
growth of dim filament ends (as in the absence of Arp2/3
complex), frequently originating in bright filament branchcate dim, buckling filaments elongated by FMNL2. Time is in seconds. Scale
led filaments increasing in length over time in the presence or absence of
ce of profilin. Filament numbers counted for actin alone or upon addition of
us assembly of 1.3 mM actin (23% ATTO 488 labeled) in the presence of the
plex, except for red ones that mark branch and/or filament end capped by
neously growing filaments, and green, blue, or white circles at the bottom
ie S4.
resence or absence of activated Arp2/3 complex at concentrations as in (F).
).
pendent measurements.
Figure 4. FMNL2 Regulates Rates of Lamellipodia Protrusion and Cell Migration
(A) Western blot using anti-FMNL2 antibody and extracts from B16-F1 cells transfected with mock construct or a vector mediating knockdown of FMNL2
(FMNL2 RNAi). a-tubulin was used as a loading control.
(B) Analysis of protrusion rates of lamellipodia formed in mock or FMNL2 knockdown cells, with transfected cells identified by GFP expression. Insets show
representative regions from images recorded by phase-contrast time-lapse microscopy and subjected to protrusion rate analyses as indicated. Time is in
minutes and seconds; scale bars in overview panels represent 20 mm and in insets 5 mm.
(C) Box and whisker plots showing results from quantification of lamellipodia protrusion velocities in mock (arithmetic mean, 1.26 mm/min; SD, 0.62 mm/min)
and FMNL2 knockdown cells (arithmetic mean, 0.96 mm/min; SD, 0.62 mm/min). The line within the box indicates median, and the box boundaries contain
50% (25%–75%) and the whiskers 80% (10%–90%) of all measurements, whereas outlying points are shown as dots. Difference in protrusion velocity was
confirmed to be statistically significant by Mann-Whitney rank sum test.
(D) Migration efficiency of B16-F1 control (arithmetic mean, 0.36 mm/min; SD, 0.13 mm/min) versus FMNL2 knockdown cells (arithmetic mean, 0.298 mm/min;
SD, 0.12 mm/min). Data were displayed and confirmed to be statistically significant as in (C). Data in (C) and (D) are derived from at least three independent
experiments.
(E) Model for FMNL2 function in lamellipodium protrusion is illustrated. Actin filaments are generated by nucleation through Arp2/3 complex or perhaps
alternative mechanisms (actin nucleator). Engagement of FMNL2 is preceded by release from autoinhibition possibly mediated by a myristoyl switch
(not shown) and by interaction with active Cdc42. FMNL2 dimers then capture preformed actin filament barbed ends and promote their elongation in
a profilin/actin-dependent manner. Elongation by FMNL2 is proposed to accelerate lamellipodium protrusion in coordination with other factors, e.g., the
Ena/VASP family member VASP. Cdc42 contributes to activation but not recruitment of FMNL2 to the lamellipodium tip, which is mediated by an unknown
factor (X) remaining to be established.
See Figure S3 and Movie S5.
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1010points (Figure 3F; Movie S4). Quantification of the number of
dim filaments in the presence or absence of activated Arp2/3
complex confirmed that most formin-captured, dim filaments
were nucleated by Arp2/3 complex (Figure 3G). Elongation
rates of individual filaments in all these conditions were
also quantified (Figure 3H). Profilin decreased elongationrates versus actin alone (Figure 3D) to about 5 subunits/s
(Figure 3H) due to the reduced rate constant for association
of profilin-actin with barbed ends [24]. Growth of filaments
nucleated by Arp2/3 complex (Figure 3H) was identical to
spontaneously nucleated ones (Figure 3D), as expected,
whereas further addition of FMNL2(21)-C in these conditions
Cdc42 Powers Lamellipodia Protrusion through FMNL2
1011markedly suppressed their growth (Figure 3H). In contrast,
the simultaneous presence of activated Arp2/3 complex,
FMNL2(21)-C, and profilin generated two populations of
growing filaments: bright ones elongating at about 5
subunits/s—presumably not captured by the formin—and
dim ones growing at 15 subunits/s (Figure 3H) apparently
accelerated by the formin in the presence of profilin-actin.
These data constitute the first demonstration of Arp2/3
complex and a formin collaborating in actin assembly
through promoting filament branching and elongation,
respectively, and suggest that FMNL2 might exert similar
functions in protruding lamellipodia.
Although Cdc42 is unessential for wound-healing migration
in fibroblasts [18], it can drive cell shape changes and induce
filopodia and lamellipodia formation, thus promotingmigration
in certain conditions [25]. It is currently unclear whether Cdc42
regulates lamellipodial protrusion only through Rac [26, 27], as
deduced from experiments using dominant-negative GTPases
[28], or also by direct interaction with downstream effectors
regulating actin dynamics. A role for the Cdc42 effector
N-WASP in lamellipodial Arp2/3 activation is unlikely due to
its absence in the lamellipodium and the lack of a phenotype
in null fibroblasts [29]. Signaling to actin dynamics through
a formin is an attractive alternative. We thus asked whether
interference with FMNL2 function abrogated or modified the
formation and dynamics of lamellipodia. We silenced FMNL2
expression in motile B16-F1 melanoma cells using RNAi,
which did not affect FMNL3 (Figure 4A; Figure S3G). Although
lamellipodia did form, their protrusion velocities were mark-
edly reduced (76.2%) compared to controls. Measurements
of protrusion rates using phase-contrast optics were
restricted to transfected, GFP-positive cells (Figure 4B; Movie
S5). The protrusion velocities of lamellipodia formed by
B16-F1 cells migrating on laminin can be correlated with accu-
mulation of lamellipodial tip markers such as VASP [30] and,
presumably, rate of actin polymerization [31]. We speculate
that lack of FMNL2 at the lamellipodium tip reduces elongation
rates of lamellipodial actin filaments and, thus, rate of forward
translocation.Whether FMNL3might serve functions similar or
differential to FMNL2 is currently unknown. However, these
and previous data suggest that Cdc42, e.g., through its
effector FMNL2, tunes lamellipodial protrusion by regulating
actin filament elongation rather than nucleation, a function
likely reserved for the Rac/WAVE/Arp2/3 pathway [1, 22, 23].
Interestingly, Drosophila S2R+ cells silenced for the sole fly
FMNL ortholog CG32138 stood out in a recent genome-wide
screen for factors regulating cell shape [32], displaying lamel-
lipodia with abnormal morphology (Figure S3H). These data
suggest that core functions of FMNL-like factors developed
early and remained conserved throughout evolution. Ineffi-
cient lamellipodium protrusion as seen upon FMNL2 knock-
down should impair B16-F1 migration, and indeed, this was
observed (Figure 4D).
In conclusion, our data uncover a novel signaling pathway
linking the Rho family GTPase Cdc42 to activation of the
FMNL subfamily member FMNL2 in migrating mesenchymal
cells. Cdc42 thus promotes lamellipodium protrusion and
migration by at least two separate mechanisms: (i) by indirect
signaling to Rac activation [26, 27], and (ii) by directly
activating FMNL formins modulating actin polymerization
rate at the lamellipodium tip. Future work should establish
the precise relevance of Arp2/3 complex versus different
formins or actin filament polymerases of the Ena/VASP family
[33, 34] in lamellipodium protrusion.Supplemental Information
Supplemental Information includes three figures, Supplemental Experi-
mental Procedures, and fivemovies and can be found with this article online
at doi:10.1016/j.cub.2012.03.064.
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